Note · 10 November 2026
Bacteriostatic Water for Peptides vs Sterile Water: The Record
Bacteriostatic water is sterile water with benzyl alcohol, usually 0.9 per cent, added to restrain microbial growth across repeated withdrawals; sterile water has nothing added and is supplied for one use. In measured work the preservative partially unfolded and aggregated some proteins, left acylated peptides without detectable interaction in two studies and protected one enzyme against heat, depending on the molecule and the conditions.
The answer: one added compound
Bacteriostatic water is sterile water with benzyl alcohol, usually 0.9 per cent, added as a preservative that restrains the growth of microbes introduced after opening; its label allows repeated withdrawals from one container. Sterile water has nothing added (no preservative, buffer or salt), and its labels limit each container to one use. In measured studies the preservative was not inert. At 0.9 per cent it perturbed the folded structure of recombinant human interferon gamma, of granulocyte colony stimulating factor at pH 7.0 and of interleukin-1 receptor antagonist at 37 degrees C and aggregated all three. It showed no detectable interaction with acylated 31-residue peptides in two studies from one group, and protected lysozyme from heat-induced aggregation. The molecule, concentration, temperature and pH set each result; no study located for this note compared a research peptide made up in the two waters.
Six pages examined for this note described the composition much as the labels do; their limits for opened sterile water, from within hours to 48 hours, and a claim that 0.9 per cent benzyl alcohol avoids peptide degradation traced to no study found.
What each liquid is, by label and pharmacopoeia
Hospira's label for bacteriostatic water, NDA 018802, describes sterile, nonpyrogenic water with 0.9 per cent (9 mg/mL) or 1.1 per cent (11 mg/mL) benzyl alcohol added as a bacteriostatic preservative, in a container from which repeated withdrawals may be made, at pH 5.7 within 4.5 to 7.0. Hu and colleagues described it more broadly in 2023 as sterile water containing one or more suitable antimicrobial agents, at the USP monograph's pH range of 4.5 to 7.0, so 0.9 per cent benzyl alcohol is one composition the definition allows rather than the definition itself. Listings for laboratory research describe the same liquid: one listing that states no salt and no buffer gives sterile water with 0.9 per cent benzyl alcohol added as a preservative, in 3, 10 and 30 mL vials.
Hikma's label for 10 mL vials, ANDA 206369, gives sterile, nonpyrogenic water with no bacteriostat, antimicrobial agent or added buffer, supplied only in containers for one use, any unused portion discarded, and prints no pH; ICU Medical's label for a 1000 mL container calls it solute-free and gives pH 5.5 within 5.0 to 7.0, so the preserved water's range reaches half a point lower. Neither liquid is buffered. Hu and colleagues found bacteriostatic water, with very low ionic strength and no buffering capacity, slow and noisy to measure, its pH results inconsistent even with potassium chloride added as the monograph specifies unless other measurement factors were also controlled. A labelled pH describes the liquid as supplied, not a solution made from it. Which solvent suits a given sequence is a separate question, taken up in this site's note on reconstituting peptides.
The preservative also changes. Sudareva and Chubarova reported in 2006 that aqueous benzyl alcohol at 0.005 to 2.09 mg/mL, below the 9 mg/mL of bacteriostatic water, oxidised over long periods to benzaldehyde and benzoic acid, in amounts that depended on starting concentration, time and conditions. Urakami and colleagues reported in 2000 that sonicating benzyl alcohol, used as a sample solvent for gas chromatography, generated benzene, toluene and benzaldehyde, which they attributed to local heat. Neither study measured a peptide solution.
Bacteriostatic, not bactericidal
Bacteriostatic describes an agent that stops microbes multiplying; bactericidal, one that kills them. The label gives benzyl alcohol the first role, yet Lucchini and colleagues reported in 1990 that aromatic alcohols, benzyl alcohol among them, killed bacteria and altered their membranes, especially in Gram-negative species, at effective concentrations that varied greatly between compounds. What the preserved liquid must show is set by the challenge tests of the US and European pharmacopoeias, USP General Chapter 51 and Ph. Eur. 5.1.3, in which known organisms are added and survivors counted at intervals. This site's note on the 28-day figure for opened bacteriostatic water traced the repeated-withdrawal class to that testing and set out its criteria, which ask for bacteria to fall over days rather than for the liquid to be sterile.
A pass belongs to the formulation tested. Lentz and colleagues reported in 2011 that the protein tenecteplase, made up at 1 mg/mL in bacteriostatic water, met the USP criteria for inhibiting microbial growth in testing run to 28 days. Heljo and colleagues found in 2015 that raising a model peptide's concentration lowered the antimicrobial efficacy of benzyl alcohol, phenol and m-cresol alike in the Ph. Eur. test, a loss they proposed arose from preservative adsorbing onto peptide oligomers. Sterile water's limitation is that absence, not its chemistry: its labels describe the same pharmacopoeial water and class its containers for one use.
What benzyl alcohol did to proteins in solution
Every study from here on was in vitro. The harm reported was partial unfolding followed by aggregation, not wholesale denaturation. Lam and colleagues reported in 1997 that 0.9 per cent benzyl alcohol changed the near-ultraviolet circular dichroism of recombinant human interferon gamma, a reading of tertiary structure, while the far-ultraviolet spectrum of secondary structure stayed unaltered; the change grew with time, came with high molecular weight aggregates, and ran faster at lower protein concentration and at higher buffer or benzyl alcohol concentration.
Mallela's group located such a change in one region. Hutchings and colleagues reported in 2013 that 3 per cent benzyl alcohol, above bacteriostatic water's 0.9 per cent, aggregated half of a 2 mM equine cytochrome c solution over four days at 37 degrees C, against none without it. At 0.8 per cent by volume, each of five preservatives enhanced partial unfolding of a predicted aggregation hot spot, and stabilising that region cut aggregation for all five. m-Cresol induced the most aggregation and chlorobutanol the least; benzyl alcohol ranked third in thermal scans and stability measurements and fourth, behind phenoxyethanol, in isothermal aggregation runs at 75 to 80 degrees C.
Rodríguez-Martínez and colleagues reported in 2011 that alpha-chymotrypsinogen A reconstituted in buffer with 0.9 per cent benzyl alcohol formed buffer-insoluble aggregates exceeding 10 per cent within 24 hours; 5,000 Da polyethylene glycol chains attached to the protein prevented this.
Temperature and pH decided whether perturbation became aggregation. In Carpenter and Randolph's group, Thirumangalathu and colleagues reported in 2006 that 0.9 per cent benzyl alcohol accelerated aggregation of recombinant human granulocyte colony stimulating factor at pH 7.0, far more at 37 than at 25 degrees C, with 1.0 M sucrose partly counteracting it; at pH 3.5 it perturbed tertiary structure but caused no aggregation, which the authors postulated was due to colloidal stability. Roy and colleagues reported that year that it did not enhance aggregation of recombinant human interleukin-1 receptor antagonist at 25 degrees C but greatly accelerated it at 37 degrees C, where calorimetry showed a hydrophobic interaction strengthening with temperature.
Where it did no harm, or helped
Other measurements ran the other way. Goyal and colleagues reported in 2009 that hen egg-white lysozyme held at 75 degrees C for 2 hours kept 22 per cent of its activity without benzyl alcohol and 33, 42 and 75 per cent with 0.5, 0.9 and 2 per cent by volume, with smaller aggregates, although benzyl alcohol lowered its thermal transition temperature.
In two studies from one group, acylated 31-residue peptides showed no detectable interaction with it. Li and colleagues reported in 2022, by nuclear magnetic resonance, that benzyl alcohol neither aggregated a peptide they called acyl-peptide A nor shifted its spectra, while 1 per cent m-cresol produced insoluble aggregates within 24 hours at room temperature. D'Addio and colleagues reported in 2021 that m-cresol and phenol interacted with a palmitoylated 31-residue peptide and changed its conformation, while benzyl alcohol did neither and raised its physical stability and solubility under salt stress; the pattern did not hold for two similar peptides. In Heljo's model peptide, m-cresol clearly enlarged reversible oligomers, phenol and benzyl alcohol less so.
A PubMed search on 10 November 2026 pairing the two waters with peptide or protein returned two direct comparisons, both on plasminogen activators; in one, Lentz and colleagues judged tenecteplase compatible with both in glass vials for up to 72 hours on monomer, single-chain and bioactivity assays.
What the pages claim, and what traces
Six pages returned by web searches on 10 November 2026 were examined for this note. Traced: the composition and container class, though one page's claim that the USP requires exactly 0.9 per cent benzyl alcohol conflicts with Hu's description of one or more suitable agents and with the 1.1 per cent presentation; pH ranges on three pages, one cited to Hu and colleagues; that bacteriostatic water restrains growth rather than sterilising, though one page's flat statement that it does not kill bacteria goes beyond Lucchini's findings; 28 days after opening, which follows the container class; that benzyl alcohol aggregates specific proteins; and, in part, that it disrupts bacterial membranes, though no study located tied that to 0.9 per cent in water.
Untraced: limits for opened sterile water of hours, 24 hours or 24 to 48 hours, on three pages, appear on no label read, and a PubMed search the same day pairing opened or punctured sterile water with hours returned five records, none testing such a limit. A claim that contaminants reach significant counts within hours, and a figure of up to 30 days for opened bacteriostatic water, matched no study found either. That 0.9 per cent benzyl alcohol avoids peptide degradation, or spares most research peptides, generalises from no study of peptides as a class. That it singles out insulin and growth hormone matched no measurement in searches pairing benzyl alcohol with either. Claims that the preservative does not slow chemical breakdown, that the water's slightly acidic pH supports peptide stability, or that the dissolved powder sets the pH rest on no research peptide measurement; only the premise that neither liquid is buffered traces. How long a made-up vial keeps is another question: this site's note on peptide storage traced the figures in circulation to supplier handbooks or to nothing.
In the measured record the two waters differ by one compound, and what it did depended on the molecule, the concentration, the temperature and the pH; the labels and the challenge test describe the container, not the solution made in it.
Disclosure. Vialog is published by the team behind Disguised Alpha, which sells the product linked in this note. The note follows the same editorial policy as every other page on this site.
References
- Hospira, Inc. Bacteriostatic water, USP (benzyl alcohol 9 mg/mL in 30 mL plastic vials; 11 mg/mL in glass vials filled to 20 mL): package insert LAB-0977-2.0, revised 08/2019. NDA 018802. DailyMed SPL setid 87d6e9dc-fe3b-4593-ac9a-d7493d1959c7, version 20, effective 22 May 2026. Description and How Supplied sections read for composition, container wording and pH. Retrieved 10 November 2026. View on dailymed.nlm.nih.gov
- Hu J, Kyad A, Burke K, Sakiyama L, Moraes De Souza C, Pope S, Blue L, Cohen D, Semin D, Goudar C. Critical Aspects of pH Measurement for Bacteriostatic Water for Injection. J Pharm Sci. 2023;112(8):2307-2310. PMID 36870668 View on pubmed.ncbi.nlm.nih.gov
- Hikma Pharmaceuticals USA Inc. Sterile water, USP, 10 mL vials: package insert revised July 2020. ANDA 206369. DailyMed SPL setid 78ef7ad3-451d-43d0-a9b6-5cf0aadca003, version 12, effective 10 April 2024 (no pH stated). Companion label read: ICU Medical, Inc. sterile water, USP, 1000 mL flexible container, package insert EN-4689, revised September 2018, NDA 018233, DailyMed SPL setid aab10f03-26ae-4dbc-a481-ef025e48b405, version 9, effective 2 November 2025 (pH 5.5, range 5.0 to 7.0). Description sections read for composition, container wording and pH. Retrieved 10 November 2026. View on dailymed.nlm.nih.gov
- Sudareva NN, Chubarova EV. Time-dependent conversion of benzyl alcohol to benzaldehyde and benzoic acid in aqueous solutions. J Pharm Biomed Anal. 2006;41(4):1380-5. PMID 16564153 View on pubmed.ncbi.nlm.nih.gov
- Urakami K, Kobayashi C, Miyazaki Y, Nishijima K, Yoshimura Y, Hashimoto K. Degradation products generated by sonication of benzyl alcohol, a sample preparation solvent for the determination of residual solvents in pharmaceutical bulks, on capillary gas chromatography. Chem Pharm Bull (Tokyo). 2000;48(9):1299-303. PMID 10993228 View on pubmed.ncbi.nlm.nih.gov
- Lucchini JJ, Corre J, Cremieux A. Antibacterial activity of phenolic compounds and aromatic alcohols. Res Microbiol. 1990;141(4):499-510. PMID 1697976 View on pubmed.ncbi.nlm.nih.gov
- Lentz YK, Joyce M, Lam X. In vitro stability and compatibility of tenecteplase in central venous access devices. Hemodial Int. 2011;15(2):264-72. PMID 21414130 View on pubmed.ncbi.nlm.nih.gov
- Heljo P, Ross A, Zarraga IE, Pappenberger A, Mahler HC. Interactions Between Peptide and Preservatives: Effects on Peptide Self-Interactions and Antimicrobial Efficiency In Aqueous Multi-Dose Formulations. Pharm Res. 2015;32(10):3201-12. PMID 25893328 View on pubmed.ncbi.nlm.nih.gov
- Lam XM, Patapoff TW, Nguyen TH. The effect of benzyl alcohol on recombinant human interferon-gamma. Pharm Res. 1997;14(6):725-9. PMID 9210188 View on pubmed.ncbi.nlm.nih.gov
- Hutchings RL, Singh SM, Cabello-Villegas J, Mallela KM. Effect of antimicrobial preservatives on partial protein unfolding and aggregation. J Pharm Sci. 2013;102(2):365-76. PMID 23169345 View on pubmed.ncbi.nlm.nih.gov
- Rodríguez-Martínez JA, Rivera-Rivera I, Griebenow K. Prevention of benzyl alcohol-induced aggregation of chymotrypsinogen by PEGylation. J Pharm Pharmacol. 2011;63(6):800-5. PMID 21585378 View on pubmed.ncbi.nlm.nih.gov
- Thirumangalathu R, Krishnan S, Brems DN, Randolph TW, Carpenter JF. Effects of pH, temperature, and sucrose on benzyl alcohol-induced aggregation of recombinant human granulocyte colony stimulating factor. J Pharm Sci. 2006;95(7):1480-97. PMID 16729274 View on pubmed.ncbi.nlm.nih.gov
- Roy S, Katayama D, Dong A, Kerwin BA, Randolph TW, Carpenter JF. Temperature dependence of benzyl alcohol- and 8-anilinonaphthalene-1-sulfonate-induced aggregation of recombinant human interleukin-1 receptor antagonist. Biochemistry. 2006;45(12):3898-911. PMID 16548517 View on pubmed.ncbi.nlm.nih.gov
- Goyal MK, Roy I, Banerjee UC, Sharma VK, Bansal AK. Role of benzyl alcohol in the prevention of heat-induced aggregation and inactivation of hen egg white lysozyme. Eur J Pharm Biopharm. 2009;71(2):367-76. PMID 18929648 View on pubmed.ncbi.nlm.nih.gov
- Li M, Falk BT, Lu X, Schroder R, Mccoy M, Xu W, Yin DH, Gindy ME, D'Addio SM, Su Y. Molecular Mechanism of Antimicrobial Excipient-Induced Aggregation in Parenteral Formulations of Peptide Therapeutics. Mol Pharm. 2022;19(9):3267-3278. PMID 35917158 View on pubmed.ncbi.nlm.nih.gov
- D'Addio SM, Su Y, Yin D, Zhang J, Kemp E, Gindy ME. Antimicrobial Excipient-Induced Reversible Association of Therapeutic Peptides in Parenteral Formulations. J Pharm Sci. 2021;110(2):850-859. PMID 32980392 View on pubmed.ncbi.nlm.nih.gov